Tamara Tugal

Part of Pharmaron Beijing Co., Ltd., Allergan Biologics Ltd. develops biologics products. The company is based in Liverpool, UK. The British company was founded in 2002 by Bernard Chan. Allergan Biologics was acquired by Pharmaron Biologics (UK) Holdings Ltd. from AbbVie, Inc. on April 30, 2021 for $165.95 million.

Lanthio Pharma BV focuses on discovering and developing lantipeptides for the generation of novel peptide therapeutics. Its product is a lanthionine-stabilized specific agonist of the AT2 receptor, which has great potential in diseases where tissue protection is important, like fibrosis. The company was founded in 2010 and is headquartered in Groningen, the Netherlands.

Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands.